Consolidated cash flow statements
(unaudited)
|
Nine months ended 30 September |
|
(thousands of €) |
2018 |
2017 |
Cash and cash equivalents at beginning of year |
1,151,211 |
973,241 |
|
|
|
Net loss |
(44,215) |
(85,855) |
|
|
|
Adjustments for: |
|
|
Tax income (–) / tax expense |
(343) |
161 |
Net financial income (–) / expense |
(8,958) |
23,142 |
Depreciation of property, plant and equipment |
2,843 |
2,701 |
Amortization of intangible fixed assets |
1,973 |
510 |
Net realized loss on foreign exchange transactions and other financial expenses paid |
(352) |
(503) |
Share-based compensation |
18,001 |
11,697 |
Decrease in provisions |
(8) |
(8) |
Increase in pension liabilities |
236 |
214 |
Loss on disposal of financial asset held at fair value through profit or loss |
3 |
|
|
|
|
|
(30,820) |
(47,942) |
|
|
|
Increase in inventories |
(1) |
(3) |
Increase in receivables |
(3,317) |
(8,240) |
Increase in payables |
30,371 |
16,464 |
Decrease in deferred income |
(93,370) |
(47,180) |
|
|
|
Cash used in operations |
(97,137) |
(86,901) |
|
|
|
Interest paid |
(1,026) |
(42) |
Interest received |
3,252 |
903 |
Income taxes paid |
(7) |
(191) |
|
|
|
Net cash flows used in operating activities |
(94,918) |
(86,231) |
|
|
|
Purchase of property, plant and equipment |
(4,259) |
(2,986) |
Purchase of and expenditure in intangible fixed assets |
(1,533) |
(233) |
Proceeds from disposal of property, plant and equipment |
1 |
– |
Decrease in restricted cash |
– |
6,453 |
Proceeds from sale of financial asset held at fair value through profit or loss |
134 |
372 |
|
|
|
Net cash flows generated / used (–) in investing activities |
(5,657) |
3,605 |
Repayment of obligations under finance leases and other debts |
(6) |
(50) |
Proceeds from capital and share premium increases, gross amount |
296,188 |
363,924 |
Issue costs paid related to capital and share premium increases |
(15,008) |
(15,790) |
Proceeds from capital and share premium increases from exercise of warrants |
5,261 |
4,935 |
|
|
|
Net cash flows generated in financing activities |
286,435 |
353,018 |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
6,596 |
(24,777) |
|
|
|
Increase in cash and cash equivalents |
192,456 |
245,615 |
|
|
|
Cash and cash equivalents at end of the period |
1,343,668 |
1,218,856 |
The accompanying notes form an integral part of these condensed consolidated financial statements.